Probably a Pepsi, but apparently there is doubt that the company will be able to continue operating. The question is who will end up with the DNA information they have collected.
On Tuesday, the company warned investors of "substantial doubt" about its ability to continue operating, as it reported that revenue had fallen to $44m (£35m) between July and September compared to $50m in the same period last year.
Losses fell to $59m from $75m.
The job cuts are expected to lead to one-off costs of $12m, including severance pay, for the plan that will result in savings of $35m.
"We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships," Ms Wojcicki said.
On Tuesday, the company warned investors of "substantial doubt" about its ability to continue operating, as it reported that revenue had fallen to $44m (£35m) between July and September compared to $50m in the same period last year.
Losses fell to $59m from $75m.
The job cuts are expected to lead to one-off costs of $12m, including severance pay, for the plan that will result in savings of $35m.
"We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships," Ms Wojcicki said.
Struggling DNA-testing site 23andMe to lay off 40% of its workers
The once-popular general DNA-testing firm holds a trove of sensitive genetic data from its customers.
www.bbc.com